| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/15/2010 | WO2010041054A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
| 04/15/2010 | WO2010040989A1 Quinolin-2-one compounds |
| 04/15/2010 | WO2010040663A1 Pyrrolidine n-benzyl derivatives |
| 04/15/2010 | WO2010040661A1 Modulators for amyloid beta |
| 04/15/2010 | WO2010019611A3 Bridged polycyclic compound based compositions for topical and oral applications |
| 04/15/2010 | WO2009149259A3 Processes for preparing tetrahydroisoquinolines |
| 04/15/2010 | WO2009125434A3 Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof |
| 04/15/2010 | WO2009024341A8 Condensed anthran i lami de derivatives as insectisides |
| 04/15/2010 | US20100094014 Excitatory amino acid receptor antagonists |
| 04/15/2010 | US20100094010 Chemical process |
| 04/15/2010 | US20100094009 Novel crystalline compound useful as glk activator |
| 04/15/2010 | US20100094005 Fluorinated derivative of quinolin-2(1h)-one, method for preparing the same and use thereof as a synthesis intermediate |
| 04/15/2010 | US20100093808 Salt and polymorph of a dpp-iv inhibitor |
| 04/15/2010 | US20100093806 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 04/15/2010 | US20100093804 novel crystalline form of lansoprazole |
| 04/15/2010 | US20100093803 Substituted dipyridyl-dihydropyrazolones and use thereof |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093798 Cyclic modulators of chemokine receptor activity |
| 04/15/2010 | US20100093795 Piperidine Derivative Used for Treating Chemokine Receptor 5 Mediated Diseases |
| 04/15/2010 | US20100093790 Isoquinoline compounds |
| 04/15/2010 | US20100093789 Sulfonamide compound |
| 04/15/2010 | US20100093785 Diamine derivatives |
| 04/15/2010 | US20100093767 Mitotic Kinase Inhibitors |
| 04/15/2010 | US20100093753 Biphenyl compounds useful as muscarinic receptor antagonists |
| 04/15/2010 | US20100093733 Amide and urea derivatives for the treatment of metabolic diseases |
| 04/15/2010 | US20100093730 Novel compounds as calcium channel blockers |
| 04/15/2010 | US20100093728 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |
| 04/15/2010 | US20100093726 Novel 4-amino-quinoline derivatives useful as anti-malaria drugs |
| 04/15/2010 | US20100093718 Compounds |
| 04/15/2010 | US20100093706 Multimediator transporter inhibitors for use in treatment of central nervous system disorders |
| 04/15/2010 | US20100093703 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 04/15/2010 | US20100093693 Modulators of cellular adhesion |
| 04/15/2010 | US20100093669 Methods for preparing oxazolidinones and compositions containing them |
| 04/15/2010 | US20100093668 N,n'-2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors |
| 04/15/2010 | US20100092542 Compositions and methods for treatment of eye disorders |
| 04/15/2010 | US20100092426 2-substituted benzimidazoles |
| 04/15/2010 | US20100092385 Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives |
| 04/15/2010 | US20100090588 Compound having triazine ring structure substituted with pyridyl group and organic electroluminescent device |
| 04/15/2010 | CA2740148A1 Activators of human pyruvate kinase |
| 04/15/2010 | CA2740095A1 Method of inducing negative chemotaxis |
| 04/15/2010 | CA2739527A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
| 04/15/2010 | CA2738870A1 Pyrrolidine n-benzyl derivatives |
| 04/15/2010 | CA2738812A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 04/15/2010 | CA2736924A1 Modulators for amyloid beta |
| 04/15/2010 | CA2736097A1 Carbazole compounds and therapeutic uses of the compounds |
| 04/14/2010 | EP2174938A1 Quinoline derivatives for modulating DNA methylation |
| 04/14/2010 | EP2174933A2 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same |
| 04/14/2010 | EP2174932A2 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same |
| 04/14/2010 | EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof |
| 04/14/2010 | EP2173737A1 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 04/14/2010 | EP2173734A2 Chemical compounds |
| 04/14/2010 | EP2173728A2 Heterocyclic modulators of pkb |
| 04/14/2010 | EP2173725A2 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| 04/14/2010 | EP2173722A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
| 04/14/2010 | EP2173721A1 A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles |
| 04/14/2010 | EP2173715A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 04/14/2010 | EP2173714A1 Piperidine derivatives as modulators of chemokine receptor activity |
| 04/14/2010 | EP2173713A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/14/2010 | EP2173354A1 Quinoxaline derivatives as pi3 kinase inhibitors |
| 04/14/2010 | EP1919869B1 Indole derivatives as ppar activators |
| 04/14/2010 | EP1796678B1 Carboxamide spirolactam cgrp receptor antagonists |
| 04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
| 04/14/2010 | EP1656141B1 Treatment for alzheimer s disease and related conditions |
| 04/14/2010 | EP1599201B1 Selective non-steroidal glucocorticoid receptor modulators |
| 04/14/2010 | EP1537078B1 Indoles having anti-diabetic activity |
| 04/14/2010 | EP1400515B1 Cyclic diamine compound having five-membered cyclic group |
| 04/14/2010 | EP1335901B1 Pharmaceutically active sulfanilide derivatives |
| 04/14/2010 | CN1995036B Optical purity alpha-substituted 2-methyl-5-nitro imidazole-1-ethanol derivative |
| 04/14/2010 | CN101693709A Bicyclic amides as kinase inhibitors |
| 04/14/2010 | CN101693708A Azasugar compound containing aryl and preparation process and application thereof |
| 04/14/2010 | CN101693695A Pyrimidine derivatives and methods of treatment related to the use thereof |
| 04/14/2010 | CN101225070B Antineoplastic medicament |
| 04/13/2010 | US7696352 Factor Xa inhibitors |
| 04/13/2010 | US7696350 exo-7-(8-H-8-aza-bicyclo[3.2.1]oct-3-yloxy)-chromen-2-one; mood disorder, depression, dysthymic disorder, bipolar disorder, cyclothymic disorder; sleep disorders; psychological disorders |
| 04/13/2010 | US7696346 Production method |
| 04/13/2010 | US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 04/13/2010 | US7696234 Histamine H3 receptor agents, preparation and therapeutic uses |
| 04/13/2010 | US7696233 Method for controlling particular insect pests by applying anthranilamide compounds |
| 04/13/2010 | US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 04/13/2010 | US7696229 Compounds having 5-HT6 receptor affinity |
| 04/13/2010 | US7696226 HIV protease inhibiting compounds |
| 04/13/2010 | US7696217 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease |
| 04/13/2010 | US7696216 Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives |
| 04/13/2010 | US7696214 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 04/13/2010 | US7696209 1(R)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-[4-(tetrahydropyran-4-yl)-piperazin-1-yl]-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl); calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 04/13/2010 | US7696204 Pharmaceutical compounds |
| 04/13/2010 | US7696196 (R)-1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate, for example; treatment of headaches, particularly migraine or cluster headaches |
| 04/13/2010 | US7696195 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 04/13/2010 | US7696193 Such as 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide; for treatment of neurological and psychiatric disorders |
| 04/13/2010 | US7695728 such as 2-Chloro-3-(2-chloro-6-fluorophenyl)-4-(2-propylamino)-6-([1,2,4]triazol-1-yl)pyridine and 4-chloro-3-(2-chloro-6-fluorophenyl)-2-(2-propylamino)-6-([1,2,4]triazol-1-yl)pyridine |
| 04/13/2010 | CA2474219C Dihydrobenzodiazepin-2-one derivatives iii |
| 04/13/2010 | CA2436220C New mandelic acid derivatives and their use as thrombin inhibitors |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/13/2010 | CA2295678C Pyridine derivatives |
| 04/08/2010 | WO2010039947A1 Novel compounds as calcium channel blockers |
| 04/08/2010 | WO2010039885A2 Crystalline forms of dexlansoprazole |
| 04/08/2010 | WO2010039793A1 Hepatitis c virus inhibitors |
| 04/08/2010 | WO2010039789A1 Spiro-imidazolone derivatives as glucagon receptor antagonists |